Revolution Medicines drops despite first FDA nod (RVMD:NASDAQ)

Reports

2

Domains carrying it

2

First reported

29 August 2026

Latest report

1 September 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 29 August 2026Revolution Medicines drops despite first FDA nod (RVMD:NASDAQ)seekingalpha.com
2. 1 September 2026Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUEsimplywall.st

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer59 reports · 51 domains · 5 September 2026
• Zealand cashes out rusfertide royalty for USD 100m ahead of FDA decision2 reports · 2 domains · 13 August 2026
• Pancreatic cancer drug approved by FDA is "exceptional moment," Boston researcher says3 reports · 3 domains · 3 September 2026
• Pasatru's FDA Approval Puts Regeneron's Rare-Disease Playbook To The Test2 reports · 2 domains · 22 August 2026
• Novartis Nets Third FDA Approval for Pluvicto in Prostate Cancer2 reports · 2 domains · 3 August 2026
• U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ...12 reports · 12 domains · 17 August 2026

◆ Share

◆ Evidence

2 reports · 2 domains

• Revolution Medicines (RVMD) Could Be 7% Below Fair Value On FDA Approval Of RASONQUEsimplywall.st · 1 September 2026
• Revolution Medicines drops despite first FDA nod (RVMD:NASDAQ)seekingalpha.com · 29 August 2026